Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Mepenzolate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 known ✓ | P20309 | 12/20 | 1.00 |
| ▸ | CHRM1 known ✓ | P11229 | 4/20 | 0.77 |
| ▸ | CHRM2 | P08172 | 11/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 5/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.97 |
| ▸ | HRH1 | P35367 | 3/20 | 0.77 |
| ▸ | RAB9A | P51151 | 1/20 | 0.76 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.62 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.62 |
| ▸ | HTR2B | P41595 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mepenzolate SCHEMBL17071946 | 1.00 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Mepenzolate SCHEMBL2994933 | 1.00 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Mepenzolate SCHEMBL99030 | 0.99 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Mepenzolate SCHEMBL17008166 | 0.99 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Mepenzolate SCHEMBL15575981 | 0.99 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Mepenzolate SCHEMBL15575855 | 0.99 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Mepenzolate SCHEMBL147471 | 0.99 | CHRM3 (1.00) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Mepenzolate SCHEMBL15865414 | 0.97 | CHRM3 (0.97) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Mepenzolate SCHEMBL9441937 | 0.97 | CHRM3 (0.97) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Mepenzolate SCHEMBL3635487 | 0.97 | CHRM3 (0.95) | CHRM3CHRM2KCNH2CYP2D6LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3854 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-20250302814-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) | 2025-10-02 | — | — | US | claimed |
| US-20250241933-A1 | METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR | APNIMED, INC. (DELAWARE) | 2025-07-31 | — | — | US | claimed |
| EP-4543431-A1 | METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR | APNIMED, INC. (DELAWARE) (US) | 2025-04-30 | — | — | EP | claimed |
| WO-2024254056-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | CATALENT ONTARIO LIMITED (CA) | 2024-12-12 | — | — | WO | claimed |
| US-20240358709-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) | 2024-10-31 | — | — | US | claimed |
| EP-3863708-B1 | MIXED IONIC CONDUCTORS AND CORRESPONDING DEVICES, SYSTEMS AND METHODS OF MAKING | BATTELLE MEMORIAL INSTITUTE (US) | 2024-09-11 | — | — | EP | claimed |
| US-20240261239-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2024-08-08 | — | — | US | claimed |
| EP-4395721-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) (US) | 2024-07-10 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| EP-0721348-A1 | MONOGLYCERIDE/LACTATE ESTER PERMEATION ENHANCER | ALZA CORPORATION (US) | 1996-07-17 | — | — | EP | claimed |
| WO-1995009006-A1 | MONOGLYCERIDE/LACTATE ESTER PERMEATION ENHANCER | ALZA CORPORATION (US) | 1995-04-06 | — | — | WO | claimed |
| US-5288503-A | WATER-PERMEABLE DIFFUSION BARRIER OF POLYVINYL ALCOHOL | SRCHEM INCORPORATED (US) | 1994-02-22 | — | — | US | claimed |
| EP-0367746-B1 | Sustained release drug-resin complexes | RICHARDSON VICKS INC (US) | 1994-02-02 | — | — | EP | claimed |
| US-5260066-A | Cryogel bandage containing therapeutic agent | SRCHEM INCORPORATED (US) | 1993-11-09 | — | — | US | claimed |
| US-4996047-A | Sustained release drug-resin complexes | RICHARDSON-VICKS, INC. (US) | 1991-02-26 | — | — | US | claimed |
| EP-0367746-A2 | Sustained release drug-resin complexes | RICHARDSON-VICKS, INC. (US) | 1990-05-09 | — | — | EP | claimed |
| EP-0140434-A2 | Pharmaceutical composition with systemic anticholineesterasic, agonistic-cholinergic and antimuscarinic activity | PRODOTTI FORMENTI S.r.l. (IT) | 1985-05-08 | — | — | EP | claimed |